RA
BSX icon

Rational Advisors’s Boston Scientific BSX Stock Holding History

Rational Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Buy
530
+35
+7% +$1.9K ﹤0.01% 166
2026
Q1 		$31.1K Hold
495
– – ﹤0.01% 138
2025
Q4 		$47.2K Buy
495
+60
+14% +$5.88K ﹤0.01% 133
2025
Q3 		$42.5K Buy
435
+3
+0.7% +$311 ﹤0.01% 140
2025
Q2 		$46.4K Buy
+432
New +$43.7K ﹤0.01% 132
2024
Q4 		– Sell
-14,200
Closed -$1.19M – 114
2024
Q3 		$1.19M Sell
14,200
-23,500
-62% -$1.85M 0.11% 81
2024
Q2 		$2.9M Buy
37,700
+9,000
+31% +$659K 0.28% 50
2024
Q1 		$1.97M Buy
+28,700
New +$1.85M 0.18% 60
2023
Q4 		– Sell
-24,904
Closed -$1.32M – 216
2023
Q3 		$1.32M Sell
24,904
-4,191
-14% -$220K 0.12% 74
2023
Q2 		$1.57M Buy
29,095
+28,691
+7,102% +$1.5M 0.13% 70
2023
Q1 		$20.2K Hold
404
– – ﹤0.01% 192
2022
Q4 		$18.7K Hold
404
– – ﹤0.01% 170
2022
Q3 		$16K Hold
404
– – ﹤0.01% 174
2022
Q2 		$15K Buy
404
+10
+3% +$407 ﹤0.01% 176
2022
Q1 		$17K Buy
+394
New +$17.1K ﹤0.01% 184
2020
Q4 		– Sell
-254
Closed -$10K – 258
2020
Q3 		$10K Sell
254
-164
-39% -$6.32K ﹤0.01% 283
2020
Q2 		$15K Buy
+418
New +$15.1K 0.01% 315
2020
Q1 		– Sell
-5
Closed – – 209
2019
Q4 		$0 Sell
5
-603
-99% -$25.2K ﹤0.01% 539
2019
Q3 		$25K Sell
608
-35,685
-98% -$1.51M 0.01% 434
2019
Q2 		$1.56M Buy
36,293
+32,940
+982% +$1.27M 0.55% 49
2019
Q1 		$129K Sell
3,353
-16,694
-83% -$638K 0.03% 234
2018
Q4 		$708K Sell
20,047
-63,570
-76% -$2.31M 0.22% 95
2018
Q3 		$3.22M Buy
83,617
+82,500
+7,386% +$2.88M 0.77% 32
2018
Q2 		$37K Buy
+1,117
New +$33.7K 0.02% 283

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Rational Advisors's BSX Position: Q2 2026 in Review

Rational Advisors increased its Boston Scientific (BSX) stake by 7.1% in Q2 2026, buying an estimated $1.9K and bringing the position to 530 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #166.

Rational Advisors first reported a position in BSX in Q2 2018 and has held it in 24 quarters since. The position peaked at $3.22M in Q3 2018. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Rational Advisors held 530 shares of Boston Scientific worth $22.6K as of Q2 2026.
  • Rational Advisors bought 35 Boston Scientific shares in Q2 2026, an estimated $1.9K.
  • Boston Scientific made up ﹤0.01% of Rational Advisors's portfolio in Q2 2026, its #166 holding.
  • Rational Advisors first reported a position in Boston Scientific in Q2 2018 and has held it in 24 quarters since.
  • Rational Advisors's Boston Scientific position peaked at $3.22M in Q3 2018.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Rational Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.